Loading...

mosque
partly-cloudy
°C,

AstraZeneca antibody cocktail works against Omicron in study

December 16, 2021 / 6:30 PM
Image for the title: AstraZeneca antibody cocktail works against Omicron in study
download-img
Sharjah 24 – Reuters: AstraZeneca said on Thursday a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron coronavirus variant, showing promise for wider use of the therapy.
The study was conducted by independent investigators of the U.S. Food and Drug Administration, the company said, adding that more analyses of Evusheld against Omicron are being conducted by AstraZeneca and third-parties, with data expected "very soon". 
 
December 16, 2021 / 6:30 PM

More on this Topic

Rotate For an optimal experience, please
rotate your device to portrait mode.